These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3218579

  • 1. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1988; 12(5):419-23. PubMed ID: 3218579
    [No Abstract] [Full Text] [Related]

  • 2. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1989; 13(1):41-3. PubMed ID: 2496584
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B, Gallego J, Boronat F, Moreno B, Mompó JA, Jiménez JF.
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract] [Full Text] [Related]

  • 4. Intravesical chemotherapy.
    Prout GR.
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract] [Full Text] [Related]

  • 5. Chemoprevention of superficial bladder cancer.
    Kamat AM.
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):799-808. PubMed ID: 14686702
    [Abstract] [Full Text] [Related]

  • 6. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Dec; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 7. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours.
    Kondás J, Szentgyörgyi E.
    Ther Hung; 1983 Dec; 31(2):55-8. PubMed ID: 6571182
    [No Abstract] [Full Text] [Related]

  • 8. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR, Kopp J.
    Prog Clin Biol Res; 1984 Dec; 162B():397-427. PubMed ID: 6438644
    [No Abstract] [Full Text] [Related]

  • 9. Management of superficial bladder carcinoma with BCG. Long term follow-up.
    Martínez-Piñeiro JA.
    Prog Clin Biol Res; 1984 Dec; 162B():335-45. PubMed ID: 6438642
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
    Jakse G.
    Prog Clin Biol Res; 1985 Dec; 185B():69-78. PubMed ID: 3898142
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J, Fernández Gómez JM, Escaf Barmadah S, González Alvarez RC, Jalón Monzón A, Martínez Gómez FJ, Sánchez Trilla A, Regadera Sejas J.
    Arch Esp Urol; 2007 Dec; 60(1):36-43. PubMed ID: 17408170
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk-adapted use of intravesical chemotherapy.
    Lerner SP, Au JL.
    BJU Int; 2008 Nov; 102(9 Pt B):1247-53. PubMed ID: 19035889
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Superficial bladder cancer--problems with selection.
    Glashan RW.
    Prog Clin Biol Res; 1985 Nov; 185B():13-8. PubMed ID: 4034586
    [No Abstract] [Full Text] [Related]

  • 19. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S, Akaza H, Ohashi Y, Kotake T.
    Cancer; 1999 Nov 01; 86(9):1818-26. PubMed ID: 10547556
    [Abstract] [Full Text] [Related]

  • 20. Local mitomycin-C therapy in relapse-prevention of superficial bladder neoplasms treated by means of laser.
    Szemes Z, Kovács R.
    Acta Chir Hung; 1994 Nov 01; 34(1-2):5-10. PubMed ID: 7604628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.